mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-07 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |